What Happens Once There is a COVID-19 Vaccine? Key Challenges to - PowerPoint PPT Presentation

What Happens Once There is a COVID-19 Vaccine? Key Challenges to Vaccinating America December 3, 2020

Agenda Introduction • Drew Altman, President and CEO Presentations • Mollyann Brodie, Executive Vice President and Executive Director of Public Opinion and Survey Research • Jennifer Kates, Senior Vice President and Director of Global Health & HIV Policy • Karyn Schwartz, Senior Fellow • Samantha Artiga, Vice President and Director of Racial Equity and Health Policy Audience Q&A – the panelists above will be joined by: • Josh Michaud, Associate Director for Global Health Policy

Willingness to Get Vaccinated Over Time Percent who say they would get a coronavirus vaccine (question wording varies): 100% Gallup NPR/PBS/Marist ABC/Ipsos Axios/Ipsos Pew CNN/SSRS KFF NYT/Sienna 74% 80% 72% 65% 64% 61% 66% 63% 60% 60% 58% 51% 51% 51% 49% 50% 40% 48% 38% 38% 20% 0% May June July August September October November SOURCE: KFF Polls, Gallup Polls, NPR/PBS/Marist Polls, ABC News/Ipsos Polls, Axios/Ipsos Polls, Pew Polls; CNN/SSRS.

Black Americans, Republicans Less Likely To Say They Would Get COVID-19 Vaccine Even If It Was Free And Determined Safe Percent who say, if a coronavirus vaccine was determined to be safe by scientists and available for free to everyone who wanted it, they would probably not or definitely not get it: Race/Ethnicity NET Party ID NET Total Total 14% 20% 14% 20% 34% 34% Black 22% 27% Democrats 12% 9% 49% 21% Hispanic 37% Independents 31% 16% 21% 12% 20% White Republicans 14% 19% 33% 20% 31% 51% SOURCE: KFF/The Undefeated Survey on Race and Health (conducted Aug. 20-Sept. 14, 2020). See topline for full question wording.

Black Adults Who Are Vaccine Hesitant Cite Safety Concerns, Distrust; More White Adults Say They Don’t Need/Want It AMONG THOSE WHO SAY THEY WOULD NOT GET A COVID-19 VACCINE: Percent who say each of the following is the main reason why (open-end) : BLACK WHITE 30% Safety concerns/side effects 39% Distrust health system, gov't, or 23% 35% vaccines in general 39% Don't need or want/Not at risk 21% 6% Concerns about process 6% 2% Concerns about effectiveness 5% SOURCE: KFF/The Undefeated Survey on Race and Health (conducted Aug. 20-Sept. 14, 2020). See topline for full question wording.

Despite Expressing Trust In The FDA, Many Worry It May Rush To Approve A Vaccine How worried are you, if at all, that the FDA will rush to approve a coronavirus vaccine without making sure that it is safe and effective, due to political pressure from President Trump and the White House? Very worried Somewhat worried Not too worried Not at all worried Total 33% 29% 17% 20% Democrats 53% 33% 8% 5% Independents 34% 34% 16% 16% Republicans 10% 19% 30% 41% 50% SOURCE: KFF Health Tracking Poll (conducted October 7-12, 2020). See topline for full question wording.

Large Shares, Especially Of Black Adults, Not Confident COVID-19 Vaccine Will Be Distributed Fairly How confident are you that when a coronavirus vaccine becomes available, it will be distributed in a way that is fair? Very confident Somewhat confident Not too confident Not at all confident Total 16% 36% 26% 20% Black 9% 23% 34% 33% Hispanic 11% 39% 28% 21% White 18% 38% 25% 17% 50% SOURCE: KFF/The Undefeated Survey on Race and Health (conducted Aug. 20-Sept. 14, 2020). See topline for full question wording.

States are All Over the Map in Their Planning

What Happens Next? • CDC ACIP initial recommendation 12/1/20, adopted by CDC Director 12/2/20 ‒ When a COVID-19 vaccine is authorized by FDA and recommended by ACIP, vaccination in the initial phase should be offered to both 1) health care personnel and 2) residents of long-term care • FDA Advisory Committee meets to review EUA requests ‒ December 10, Pfizer-BioNTech Vaccine ‒ December 17, Moderna Vaccine • If EUA is approved, vaccine in 24-48 hours ‒ 6.4 million doses initially, for total of 40 million doses in December (20 million people) ‒ To be distributed based on state’s share of adult population ‒ Centralized and direct distribution, depending on vaccine • Massive, unprecedented effort (and 51+ different vaccine plans)

What will President-Elect Biden Do?

How Will Initial Doses of COVID-19 Vaccines Be Covered by Insurance? Private Medicare Medicaid Uninsured Insurance No cost sharing for vaccine or its administration NOTE: Some insurance requirements are tied to the public health emergency and will end when or soon after the public health emergency ends. Initial doses are doses purchased directly by the U.S. government.

Preventing racial gaps in uptake of a COVID-19 vaccine is important for mitigating health disparities. COVID-19 mortality rates by race/ethnicity per 100,000 people as of November 25, 2020: Total: 240,213 deaths 120.1 118.2 84.1 81.6 68.7 51.4 White Black Hispanic Asian American Indian Native Hawaiian or Alaska Native or Other Pacific Islander NOTE: Persons of Hispanic origin may be of any race but are categorized as Hispanic; other groups are non-Hispanic. SOURCE: CDC, Provisional Death Counts for Coronavirus Disease (COVID-19): Distribution of Deaths by Race and Hispanic Origin, https://data.cdc.gov/NCHS/Provisional-Death-Counts-for-Coronavirus-Disease-C/pj7m-y5uh as of November 25, 2020 and KFF analysis of the 2008- 2019 American Community Survey, 1-Year Estimates.

Prior vaccine experience shows people of color are less likely to be vaccinated compared to their White counterparts. Influenza Vaccination Rates among Adults by Race and Ethnicity, 2018-2019 Season: 49% 44% 39% 37% 38% White Black Hispanic Asian American Indian or Alaska Native NOTES: Adults are age 18 and older. Persons of Hispanic origin may be of any race but are categorized as Hispanic; other groups are non-Hispanic. SOURCE: Centers for Disease Control and Prevention, Flu Vaccination Coverage, United States 2019-2019 Season, https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm

People of color are more likely to face access-related barriers to vaccination, including higher uninsured rates. Uninsured rate among the nonelderly population by race/ethnicity 2019: 21.7% 20.0% 12.7% 11.4% 7.8% 7.2% White Black Hispanic Asian AIAN NHOPI NOTE: Persons of Hispanic origin may be of any race but are categorized as Hispanic for this analysis; other groups are non-Hispanic. Includes individuals ages 0 to 64. SOURCE: KFF estimates based on the 2008-2019 American Community Survey, 1-Year Estimates.

Historic and ongoing racism and discrimination also create barriers to vaccination for people of color. Share of the Adults who Reported that a Doctor/Health Care Provider did the Following in the Last Three Years: Black Hispanic White 22% 19% 18% 18% 17% 12% 13% 12% 11% Didn't believe they Refused to order a test or treatment Refused to prescribe pain were telling the truth they thought they needed medication they thought they needed SOURCE: KFF/The Undefeated Survey on Race and Health (conducted Aug. 20-Sept. 14, 2020). See topline for full question wording.

Prioritizing equity, facilitating access, and providing outreach and education can reduce barriers to vaccination. • Prioritizing equity ‒ 25 of 47 publicly available state plans incorporate racial equity into prioritization plans ‒ 12 of 47 publicly available state plans mention efforts to include providers to reach diverse populations ‒ 23 of 47 publicly available state plans mention communication plans to reach diverse populations • Facilitating access ‒ Making it easily accessible (locations, modes of access, hours) ‒ Ensuring people know it is available at no cost • Providing effective outreach and education ‒ Systems and providers proactively working to earn trust and address safety concerns ‒ Utilizing trusted messengers with shared background and experiences ‒ Producing linguistically and culturally appropriate materials

Contact Information and Additional Resources Ashley Joyce Communications Associate, Marketing Email: ajoyce@kff.org Phone: (202) 654-1348 An archived version of the webinar will be posted online later today. We will notify attendees by email when it is available. For more analysis of COVID-19 vaccine distribution and other national health issues, visit our website: KFF.org